Minerva Neurosciences Stock

Minerva Neurosciences Dividend 2024

Minerva Neurosciences Dividend

0 USD

Minerva Neurosciences Dividend yield

Ticker

NERV

ISIN

US6033801068

WKN

A1171S

How much dividend does Minerva Neurosciences 2024 pay?

According to the latest status from September 2024, Minerva Neurosciences paid a total of 0 USD per share in dividends within the last 12 months. With the current Minerva Neurosciences price of 2.82 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Minerva Neurosciences Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Minerva Neurosciences Dividend Safe?

Minerva Neurosciences has been increasing the dividend for 0 years.

Over the past 10 years, Minerva Neurosciences has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Minerva Neurosciences's Dividend Distributions

Minerva Neurosciences’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Minerva Neurosciences's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Minerva Neurosciences's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Minerva Neurosciences’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Minerva Neurosciences Aktienanalyse

What does Minerva Neurosciences do?

Minerva Neurosciences was founded in 2007 and is a biopharmaceutical company focused on developing therapies for various psychiatric and neurological disorders. The company's business model is based on identifying promising molecules and developing them clinically until they are approved by health authorities. Minerva works closely with academic institutions and other partners to expand its pipeline of potential products. The company is focused on developing therapies for disorders such as schizophrenia, depression, sleep disorders, Parkinson's, and Alzheimer's. Minerva Neurosciences' main products are the antipsychotic MIN-101, targeting the treatment of schizophrenia, and the antidepressant MIN-117, developed for the treatment of depression. Both products are currently in clinical development and have the potential to offer new treatment options for patients. Furthermore, Minerva Neurosciences has entered into exclusive licensing agreements with other companies to develop innovative therapies for rare diseases. One of these products is the medication Roluperidone, which can be used for schizophrenic disorders. Minerva Neurosciences is divided into three business segments: Minerva Neurosciences Inc, Minerva Manufacturing Inc, and Minerva Therapeutics Inc. Minerva Manufacturing has its own research and development department and specializes in manufacturing clinical trial products. Minerva Therapeutics is a subsidiary focused on developing gene therapies for rare diseases. The company aims to improve the quality of life for patients with neurological and psychiatric disorders. Minerva Neurosciences pursues a strategy of collaborating with external partners and academic institutions to foster innovation and develop new therapies. Overall, Minerva Neurosciences has the potential to play a significant role in the treatment of central nervous system disorders and improve the health and well-being of millions of people worldwide. Minerva Neurosciences is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Minerva Neurosciences stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Minerva Neurosciences stock

How much dividend does Minerva Neurosciences pay?

Over the past 12 months, Minerva Neurosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Minerva Neurosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Minerva Neurosciences?

The current dividend yield of Minerva Neurosciences is .

When does Minerva Neurosciences pay dividends?

Minerva Neurosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Minerva Neurosciences?

Minerva Neurosciences paid dividends every year for the past 0 years.

What is the dividend of Minerva Neurosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Minerva Neurosciences located?

Minerva Neurosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Minerva Neurosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Minerva Neurosciences from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Minerva Neurosciences pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of Minerva Neurosciences in the year 2023?

In the year 2023, Minerva Neurosciences distributed 0 USD as dividends.

In which currency does Minerva Neurosciences pay out the dividend?

The dividends of Minerva Neurosciences are distributed in USD.

Andere Kennzahlen von Minerva Neurosciences

Our stock analysis for Minerva Neurosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Minerva Neurosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.